Cutting through the noise: 12th edition of Global Forum on Nicotine to address effective communications for tobacco harm reduction

2Firsts Events
Feb.13.2025
Cutting through the noise: 12th edition of Global Forum on Nicotine to address effective communications for tobacco harm reduction
Registration is open for the annual Global Forum on Nicotine (GFN) which will hold its twelfth edition this summer in Warsaw, Poland, from Thursday 19 to Saturday 21 June 2025 at the Presidential Hotel, Warsaw (formerly the Marriott). Challenging perceptions - effective communication for tobacco harm reduction will discuss ways to overcome one of the major obstacles to widespread adoption of an approach that could dramatically improve the health of millions of people who smoke.

• Evidence for tobacco harm reduction is growing, alongside consumer uptake of safer nicotine products;

• Yet risk perceptions and public understanding of their role in smoking cessation are deteriorating;

• Experts at GFN in June will address the communications issues impeding progress for tobacco harm reduction. 


Registration is open for the annual Global Forum on Nicotine (GFN) which will hold its twelfth edition this summer in Warsaw, Poland, from Thursday 19 to Saturday 21 June 2025 at the Presidential Hotel, Warsaw (formerly the Marriott). Challenging perceptions - effective communication for tobacco harm reduction will discuss ways to overcome one of the major obstacles to widespread adoption of an approach that could dramatically improve the health of millions of people who smoke.

 

Since the turn of the millennium, there have been huge technological advances in nicotine delivery systems. Products such as vapes, pouches, pasteurised snus and heated tobacco products all offer significantly safer ways to use nicotine than combustible cigarettes, decoupling the intake of nicotine, a relatively low risk substance, from the substantial health risks of inhaling tobacco smoke, or using risky oral tobaccos.

 

In many countries, including Aotearoa New Zealand, Japan, Norway, Sweden and the UK, consumer uptake of SNP has accelerated falling smoking rates; in some markets, sales are now challenging the dominance of the combustible cigarette. Yet this headway is being slowed by a paradox: as the scientific evidence in favour of tobacco harm reduction continues to grow, popular opinion about safer nicotine products is deteriorating.  

 

Internationally, bans and restrictions are proliferating. Media discourse and some public health messaging focuses on scare stories about safer nicotine products, while ignoring the massive ongoing health crisis caused by tobacco use.(1,2) One 2024 study of over 28,000 adults who smoke in England found that the last decade has seen harm perceptions of vaping worsen substantially, to the extent that most adults who smoked in 2023 falsely believed vapes to be equally as or more harmful than cigarettes.(3) The net result is that more people will continue to smoke for longer.
 

For GFN Conference Director Jessica Harding, the focus on effective communications emerged from a milestone reached in the development of the approach. “We’re now a quarter of a century into harm reduction for risky tobacco use,” she says. “Millions have already used safer nicotine products to quit smoking, but it’s too slow, and messaging is a big part of this. We’ve got to make the case effectively with policymakers, but it’s also crucial at grassroots level, from consumer to consumer, helping those still smoking find their own route to switch or quit.” 

 

GFN25: Challenging perceptions - effective communication for tobacco harm reduction will encourage reflection, discussion and debate on how professionals and consumers can combat the misunderstandings, misconceptions and mischaracterisations that are putting the brakes on progress. The event will bring together global experts on nicotine and tobacco harm reduction, consumer advocates and those with expertise in complex messaging. Registration is open now, with discounted accommodation rates available until 15 May.

 

Each day will feature keynote presentations, followed by commentary from a respondent and the opportunity for Q&A from the audience, both in the room and online. Moderated panel discussions and workshops will have similar opportunities for audience engagement and participation. The conference organisers offer onsite and online translation facilities into Spanish and Russian for much of the event, and a Spanish-language session will allow an in-depth focus on Iberoamerican issues. The day before the conference, Wednesday 18 June, will be devoted to side and satellite meetings, many open to registered delegates.

 

The Global Forum on Nicotine’s broadcast arm, GFN TV, will again provide live commentary on the event, and all who register have the opportunity to contribute content and share tobacco harm reduction research, advocacy or views. Submissions are being sought for GFNFives, the ScienceLab and the GFN Film Festival before the deadline of 14 May, as well as for the inaugural GFN Photo Festival, a new addition to the creative component of the conference.

 

2Firsts will continue to serve as an official media partner of GFN, bringing the latest coverage to industry professionals worldwide.

 


For more information and to register your interest in attending GFN25 as a media representative, please contact: media@gfn.events 

 

Click to download GFN25 logos and images of last year’s event for editorial use. All images © Global Forum on Nicotine.

 


Notes to editors:

 

(1) Pesko, MF, Cummings, KM et al: (2023), United States public health officials need to correct e-cigarette health misinformation. Addiction, 118: 785-788. https://doi.org/10.1111/add.16097

(2) Balfour, DJ, Benowitz, NL et al: (2021) Balancing Consideration of the Risks and Benefits of E-Cigarettes. American Journal of Public Health 111, 1661_1672, https://doi.org/10.2105/AJPH.2021.306416

 

(3) Jackson SE, Tattan-Birch H et al: (2024) Trends in Harm Perceptions of E-Cigarettes vs Cigarettes Among Adults Who Smoke in England, 2014-2023. JAMA Netw Open. 2024;7(2):e240582. https://doi.org/10.1001/jamanetworkopen.2024.0582    

 


Dates and location: The Global Forum on Nicotine 2025: Challenging perceptions - effective communication for tobacco harm reduction (#GFN25) runs from Thursday 19 until Saturday 21 June, with side events taking place on Wednesday 18 June, at the Warsaw Presidential Hotel, Al. Jerozolimskie 65/79, Warsaw 00-697 Poland. The hotel was formerly known as the Marriott Warsaw Centrum.

 
Conference audience: The Global Forum on Nicotine is the only global event that welcomes all stakeholders involved with new and safer nicotine products, including: consumers and consumer advocates; public health experts; policy analysts, parliamentarians and government officials; academics and researchers; product manufacturers and distributors; and media representatives.


Funding declaration: The Global Forum on Nicotine does not receive sponsorship from manufacturers, distributors or retailers of nicotine products including pharmaceutical, vaping and tobacco companies. Conference-supporting organisations endorse the event, but have no financial or administrative involvement in organisation of the event.

 

Conference organisers: The Global Forum on Nicotine is organised by Global Forum on Nicotine Limited, an events company committed to providing a platform for global public health debate, knowledge exchange and networking, underpinned by the principles of inclusiveness and multi-sectoral engagement.

 

2Firsts will continue to serve as an official media partner of GFN, bringing the latest coverage to industry professionals worldwide.

 


 

2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10